Press Releases Archives - Page 39 of 103 - Lupin

BSE 2273.90 NSE 2276.20

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2273.90 NSE 2276.20

Lupin Receives Approval for Sevelamer Carbonate Tablets

January 25, 2021

Notice of Q3 FY2021 Board Meeting

January 14, 2021

Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets

January 7, 2021

Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP

January 6, 2021

Lupin launches Mycophenolate Mofetil Tablets USP

December 29, 2020

Lupin Receives Tentative Approval for Efinaconazole Topical Solution

December 24, 2020

Lupin Receives Approval for Rufinamide Oral Suspension

December 21, 2020

Intimation to the Stock Exchange on LPI Gavis settlement

December 16, 2020

Lupin launches Tacrolimus Capsules USP

November 25, 2020

Lupin Announces FDA Filing Acceptance of Supplemental New Drug Application for Solosec® (secnidazole) for the Treatment of Trichomoniasis

November 16, 2020

1 2 … 38 39 40 … 102 103

Search

Hit enter to search or ESC to close